These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3778276)

  • 21. DNA ploidy and S-phase fraction as prognostic factors in patients with uveal melanomas.
    Karlsson M; Boeryd B; Carstensen J; Kågedal B; Wingren S
    Br J Cancer; 1995 Jan; 71(1):177-81. PubMed ID: 7819036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognostic factors for uveal melanoma].
    Amiryan AG; Saakyan SV
    Vestn Oftalmol; 2015; 131(1):90-95. PubMed ID: 25872392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
    Isager P; Ehlers N; Overgaard J
    Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective study of surveillance testing for metastasis in 100 high-risk uveal melanoma patients.
    Piperno-Neumann S; Servois V; Mariani P; Plancher C; Lévy-Gabriel C; Lumbroso-Le Rouic L; Couturier J; Asselain B; Desjardins L; Cassoux N
    J Fr Ophtalmol; 2015 Jun; 38(6):526-34. PubMed ID: 25978872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of BRAF mutation in primary uveal melanoma.
    Cohen Y; Goldenberg-Cohen N; Parrella P; Chowers I; Merbs SL; Pe'er J; Sidransky D
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2876-8. PubMed ID: 12824225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytogenetics and prognosis for uveal melanoma in Korean patients.
    Lee CS; Lee J; Choi JJ; Yang WI; Yoon JS; Lee SY; Lee SC
    Acta Ophthalmol; 2011 Jun; 89(4):e310-4. PubMed ID: 21310015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eye-wall resection.
    Char DH; Miller T; Crawford JB
    Trans Am Ophthalmol Soc; 2000; 98():153-9; discussion 159-61. PubMed ID: 11190019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing Prognosis in Uveal Melanoma.
    Correa ZM
    Cancer Control; 2016 Apr; 23(2):93-8. PubMed ID: 27218785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical predictors of survival in metastatic uveal melanoma.
    Lorenzo D; Piulats JM; Ochoa M; Arias L; Gutiérrez C; Català J; Cobos E; Garcia-Bru P; Dias B; Padrón-Pérez N; Caminal JM
    Jpn J Ophthalmol; 2019 Mar; 63(2):197-209. PubMed ID: 30796549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No differences in outcome between radical surgical treatment (enucleation) and stereotactic radiosurgery in patients with posterior uveal melanoma.
    Furdova A; Slezak P; Chorvath M; Waczulikova I; Sramka M; Kralik G
    Neoplasma; 2010; 57(4):377-81. PubMed ID: 20429631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas.
    Mäkitie T; Summanen P; Tarkkanen A; Kivelä T
    J Natl Cancer Inst; 1999 Feb; 91(4):359-67. PubMed ID: 10050870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of epidermal growth factor receptor restricted to macrophages in uveal melanoma.
    Scholes AG; Hagan S; Hiscott P; Damato BE; Grierson I
    Arch Ophthalmol; 2001 Mar; 119(3):373-7. PubMed ID: 11231770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on Metastatic Uveal Melanoma: Progress and Challenges.
    Spagnolo F; Picasso V; Spano L; Tanda E; Venzano C; Queirolo P
    BioDrugs; 2016 Jun; 30(3):161-72. PubMed ID: 27000042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic associations of insulin-like growth factor-1 receptor in primary uveal melanoma.
    Al-Jamal RT; Kivelä T
    Can J Ophthalmol; 2011 Dec; 46(6):471-6. PubMed ID: 22153631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma.
    Ewens KG; Lalonde E; Richards-Yutz J; Shields CL; Ganguly A
    BMC Cancer; 2018 Nov; 18(1):1172. PubMed ID: 30477459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of heterozygosity of 1p in uveal melanomas with monosomy 3.
    Häusler T; Stang A; Anastassiou G; Jöckel KH; Mrzyk S; Horsthemke B; Lohmann DR; Zeschnigk M
    Int J Cancer; 2005 Oct; 116(6):909-13. PubMed ID: 15849744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uveal melanoma trapped in the temple of doom.
    Shields CL; Ganguly A; O'Brien J; Sato T; Shields JA
    Am J Ophthalmol; 2012 Aug; 154(2):219-21. PubMed ID: 22813447
    [No Abstract]   [Full Text] [Related]  

  • 38. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma.
    Aalto Y; Eriksson L; Seregard S; Larsson O; Knuutila S
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):313-7. PubMed ID: 11157859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of M2-macrophages in uveal melanoma and relation with survival.
    Bronkhorst IH; Ly LV; Jordanova ES; Vrolijk J; Versluis M; Luyten GP; Jager MJ
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):643-50. PubMed ID: 20811059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MOLECULAR PROGNOSTICS FOR UVEAL MELANOMA.
    Seider MI; Mruthyunjaya P
    Retina; 2018 Feb; 38(2):211-219. PubMed ID: 28665870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.